MENU
VRNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Verona Pharma (VRNA) Ownership - Who owns Verona Pharma?
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.13B
P/E Ratio
N/A
Total Cash
399.76M
Projected Growth
N/A
Total Debt
122.7M
Revenue
42.28M
Risk (Beta)
-0.48
Dividend Yield
N/A
Total Cash/Share
4.70
Total Debt/Equity
N/A
Revenue/Share
0.52 USD as % of share price
Fundamentals
VRNA
Capitalization
5.13B
P/E Ratio
N/A
Risk (Beta)
-0.48
Dividend Yield
N/A
Total Cash
400M
Total Cash/Share
4.70
Total Debt
123M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.52%
Revenue
42.3M
ROE
N/A
Book Value
205M
P/B Ratio
24.10
Cash Flow
N/A
Earnings
-2.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
45M
Current Ratio
10.63
Current Revenue Per Employee
175382.78
Dividends Per Share - Security
N/A
EBITDA
-138.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
94.44
Revenue To Assets
-44.33
Shares Held By Institutions
4.23B
Shares Outstanding - Current
85M
Total Liabilities
270M
Total Volume MTD
N/A
Value
-1
Gain YTD
25.086
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com